U.S. Life Science 2014 Top 10 Predictions

IDC
January 12, 2014
11 Pages - SKU: IDC5185774
Countries covered: United States

U.S. Life Science 2014 Top 10 Predictions

This IDC Health Insights report identifies several major trends that we believe will impact life science companies in 2014.

"The role of technological innovation in life science industry transformation has never been more important as companies seek to explore dramatically different business models and expand their view to both healthcare ecosystem and direct-to-patient opportunities. With renewed willingness to consider best practices from outside of the industry, cloud, big data and analytics, mobility, and social media are creating new opportunities to inform and prioritize research, commercialize promising new drugs, improve patient outcomes, better manage branding, and improve processes across the ecosystem. We expect 2014 to focus on operational excellence and new agile business models designed to better capture and exploit advances as they occur," according to Scott Lundstrom, vice president of research, IDC Health Insights.




More Manufacturing, Packaging & Detailing reports by IDC

Perspective: StudyOptimizer — Empowering Clinical Trial Enrollment Collaboration at Big Pharma by IDC
This IDC Health Insights Perspective highlights a case study that embodies many of the best practices that will empower successful collaboration in the life science ...
Japan Healthcare IT Leading Trends in 2Q12 and Life Science and Pharmaceutical Value Chain 2012 by IDC
This IDC study, reviews the key policies in the Japan healthcare IT market as of 2Q12. It summarizes the system trends and vendor and product ...
Perspective: The Importance of "Onsite" in Offshore by IDC
This IDC Health Insights Perspective examines outsourcing within the life science industry, discusses different resource models, and highlights the importance of always utilizing onsite resources ...
Best Practices: Drug Safety in the Life Science Industry — A Market Landscape by IDC
This IDC Health Insights report lays out the changing landscape for drug safety in the life science industry with a focus on the key processes, ...
See all reports like this >>

More United States Manufacturing, Packaging & Detailing reports

Biological Product (except Diagnostic) Manufacturing Industry - the U.S. and its International Trade [2014 Q3 Edition] by Supplier Relations US, LLC
The Biological Product (except Diagnostic) Manufacturing Industry report contains the most recent data and analysis on the industry's key financial data, cost and pricing, competitive ...
Pharmaceutical Preparation Manufacturing Industry - the U.S. and its International Trade [2014 Q3 Edition] by Supplier Relations US, LLC
The Pharmaceutical Preparation Manufacturing Industry report contains the most recent data and analysis on the industry's key financial data, cost and pricing, competitive landscape, industry ...
Medicinal and Botanical Manufacturing Industry - the U.S. and its International Trade [2014 Q3 Edition] by Supplier Relations US, LLC
This 2014 Q3 publication of Medicinal and Botanical Manufacturing Industry report is the comprehensive market research guide for the industry. It contains the latest ...
Pharmaceuticals and Healthcare Report - United States Q3 2014 by Business Monitor International
United States Pharmaceuticals and Healthcare Report Q3 2014BMI View: The US will remain the most attractive pharmaceutical market in the world for the foreseeablefuture. There ...
See all reports like this >>

More United States reports

The 2013-2018 Outlook for Collagen and (hyaluronic Acid) HA-Based Biomaterials in the United States by Icon Group International, Inc.
The 2013-2018 Outlook for Collagen and (hyaluronic Acid) HA-Based Biomaterials in the United StatesThis econometric study covers the latent demand outlook for collagen and (hyaluronic ...
The 2013-2018 Outlook for Relish in the United States by Icon Group International, Inc.
This econometric study covers the latent demand outlook for relish across the states and cities of the United States. Latent demand (in millions of U.S. ...
D&B Country RiskLine Report: The United States of America by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country Report: The United States of America by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
See all reports like this >>

 

SELECT A LICENSE

    Online Download  USD 4,500  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!